|
Budko A.A., Georginova O.A.
Reactivation of cytomegalovirus infection in a rheumatoid arthritis patient with immunosuppressive therapy in the background
|
№3 / 2022
|
|
Lyalina V.V., Skripnichenko E.A., Binyakovsky R.V., Borisovskaya S.V., Dolgopolova V.S., Demuria T.T., Babayan D.V., Bocharov A.A., Polyakova Yu.V., Gulshin V.A., Modestova A.V., Nikitin I.G.
Rheumatoid factor in general medical practice. Part II – detectability and clinical significance in nonrheumatological diseases
|
№2 / 2022
|
|
Lyalina V.V., Skripnichenko E.A., Binyakovsky R.V., Borisovskaya S.V., Dolgopolova V.S., Demuria T.T., Babayan D.V., Bocharov A.A., Polyakova Yu.V., Gulshin V.A., Modestova A.V., Nikitin I.G.
Rheumatoid factor in general medical practice. Part I – special features of laboratory diagnostics, detectability and clinical significance in rheumatological diseases
|
№2 / 2022
|
|
Karateev A.E.
Rheumatological problems with COVID-19: from arthralgia to rheumatoid arthritis
|
№2 / 2022
|
|
Mazurov V.I., Melnikov Е.S., Bashkinov R.A.
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk
|
№10 / 2021
|
|
Eliseeva l.N., Kartashova S.V.
Mexidol® and mexidol® forte 250 in consecutive therapy of cognitive disorders in comorbid patients with joint pathology on the background of arterial hypertension and ischemic heart disease
|
№6 / 2020
|
|
Nesterovich I.I., Nochevnaya K.V., Rabik Y.D., Vasina L.V., Speranskaya A.A., Zolotnitskaya V.P., Amosov V.I., Trofimov V.I., Vlasov T.D.
Signs of pulmonary damage according to X-ray examinations data in rheumatic arthritis patients with different serological profile
|
№6 / 2019
|
|
Bakirov B.A., Zaripova G.R., Akbuldina K.R., Bogdanova Yu.A., Kudlai D.A.
Russian and foreign experience of evaluating adherence to long-term therapy in patients with rheumatic arthritis: review of literature
|
№2 / 2019
|
|
A.P. Rebrov, M.A. Tyapkina, O.G. Karpova
Renal dysfunction and cardiovascular risk in rheumatic arthritis patients
|
№4 / 2018
|
|
L.V. Kondratieva, T.V. Popkova, Ye.L. Nasonov
Prevalence of traditional risk factors for type 2 diabetes mellitus in patients with rheumatoid arthritis
|
№4 / 2017
|
|
Ye.L. Nasonov
Pharmacotherapy of rheumatoid arthritis
|
№4 / 2017
|
|
O.A. Gromova, I.Yu. Torshin, Ye.A. Dibrova, A.V. Gilels, B.I. Demidov
Human placenta hydrolyzates in reconstructive therapy of connective tissue of cartilage and joints
|
№6 / 2016
|
Русский
